Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Divalproex Sodium ER in Adolescent Migraine Prophylaxis
NCT00195754Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of divalproex sodium in migraine, sponsored by Abbott Laboratories. Primary endpoint: Safety outcome measure at 12 months. Started Jul 2004; status: completed.
02
Drugs
divalproex sodium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00195754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195754.